Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer’s disease: Design, synthesis, in-vitro, in-vivo and in-silico studies
Fahad Hussain, Ayesha Tahir, Hafiz Muzzammel Rehman, et al.
European Journal of Medicinal Chemistry (2025) Vol. 287, pp. 117327-117327
Closed Access
Development of novel rivastigmine derivatives as selective BuChE inhibitors for the treatment of AD
Yuting Li, Qiyao Zhang, Xinxin Wang, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108245-108245
Closed Access
Postbiotics as a Therapeutic Tool in Alzheimer's Disease: Insights into Molecular Pathways and Neuroprotective Effects
Garry Hunjan, Khadga Raj Aran
Ageing Research Reviews (2025), pp. 102685-102685
Closed Access
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
The role of the gut microbiome in Alzheimer's disease pathophysiology
Alejandro Borrego-Ruiz, Juan J. Borrego
Current Opinion in Neurology (2025)
Closed Access
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access
From Genetics to Neuroinflammation: The Impact of ApoE4 on Microglial Function in Alzheimer’s Disease
Daniela Dias, Camila C. Portugal, João B. Relvas, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 243-243
Open Access
Exploring the Aβ Plaque Microenvironment in Alzheimer’s Disease Model Mice by Multimodal Lipid-Protein-Histology Imaging on a Benchtop Mass Spectrometer
Elisabeth Müller, Thomas Enzlein, Dagmar Niemeyer, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 252-252
Open Access
Artificial intelligence-driven development of natural multi-target derivatives with BuChE inhibitory activity for treating Alzheimer's disease
Qiyao Zhang, Yuting Li, Qunhua Jin, et al.
Chinese Chemical Letters (2025), pp. 110964-110964
Closed Access
Phytomolecules as Alzheimer’s Therapeutics: A Comprehensive Review
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access
Promising Natural Remedies for Alzheimer’s Disease Therapy
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 922-922
Open Access
Oral Health Status and Factors Associated with Oral Health in Patients with Alzheimer’s Disease: A Matched Case-Control Observational Study
Reza Aghasizadeh Sherbaf, George Michael Kaposvári, Katalin Nagy, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1412-1412
Open Access
Indole-3-Propionic Acid Attenuates Neuroinflammation and Cognitive Deficits by Inhibiting the RAGE-JAK2-STAT3 Signaling Pathway
Zhizhong Hao, Rong Ji, Yujing Su, et al.
Journal of Agricultural and Food Chemistry (2025) Vol. 73, Iss. 9, pp. 5208-5222
Closed Access
Diabetes and Hypertension at Midlife Predict Increases in Biomarkers of Dementia Among Black Americans
Ronald L. Simons, Mei Ling Ong, Man‐Kit Lei, et al.
Journal of Racial and Ethnic Health Disparities (2025)
Closed Access
From algorithm to applications: Artificial intelligence – A future prospective in medicine
T.N. Sriram, G. B. Gour
Sri Ramachandra Journal of Health Sciences (2025) Vol. 4, pp. 44-52
Closed Access
1-Eplupinine enhances cognition and reduces inflammation in scopolamine-induced dementia model mice
Chenhui Zhang, Jiyi Xu, Fang Xu, et al.
Neuroscience Letters (2025) Vol. 852, pp. 138184-138184
Closed Access
Revealing Lingonberry’s Neuroprotective Potential in Alzheimer’s Disease Through Network Pharmacology and Molecular Docking
J Li, Mian Wang, Yi Wang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2363-2363
Open Access
The anti-Alzheimer's Disease effects of ganoderic acid A by inhibiting ferroptosis-lipid peroxidation via activation of the NRF2/SLC7A11/GPX4 signaling pathway
Qingyang Lu, Nan Shao, Zengjun Fang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111459-111459
Closed Access
Hippocampal Sclerosis: A Review on Current Research Status and Its Mechanisms
Ting Zhao, Xiaoxiao Cui, X.B Zhang, et al.
Ageing Research Reviews (2025), pp. 102716-102716
Closed Access
Advancing Alzheimer's Therapy with Moringa oleifera: Bioactive Insights, Mechanistic Pathways, and Strategies for Efficacy and Standardization
Nasim Zamani, Faidruz Azura Jam, L. Yi, et al.
The Open Medicinal Chemistry Journal (2025) Vol. 19, Iss. 1
Open Access
Going beyond ATP binding site as a novel inhibitor design strategy for tau protein kinases in the treatment of alzheimer's disease: A review
Marwa A. Zaater, Ahmed M. El Kerdawy, Walaa R. Mahmoud, et al.
International Journal of Biological Macromolecules (2025), pp. 142141-142141
Closed Access
Exploring Alzheimer's Disease Treatment: Established Therapies and Novel Strategies for Future Care
Urvashi Soni, Kuldeep Singh, Divya Jain, et al.
European Journal of Pharmacology (2025), pp. 177520-177520
Closed Access
Perimenopause promotes neuroinflammation in select hippocampal regions in a mouse model of Alzheimer’s disease
Roberta Marongiu, Jimcy Platholi, Laibaik Park, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Experimental and theoretical studies on structural changes in the microtubule affinity-regulating kinase 4 (MARK4) protein induced by N-hetarenes: a new class of therapeutic candidates for Alzheimer’s disease
Ashanul Haque, Khalaf M. Alenezi, Mohd. Saeed Maulana Abdul Rasheed, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Positive Effects of Seabuckthorn oil on Scopolamine Induced PC12 Cell Damage and APP/PS1 Mice
Dongliang Yang, Song Zhang, Duo Wang, et al.
Natural Product Communications (2025) Vol. 20, Iss. 3
Open Access

Scroll to top